Clinical Trial Update: Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss [Phase 3]

View source ↗

Summary

Phase 3 trial update for OMA102 targeting female pattern baldness, focusing on efficacy and safety; the study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Female Pattern Baldness

Drugs mentioned

• OMA102

Snippet

Sponsor: EMS | Conditions: Female Pattern Baldness | Phase 3 | Status: NOT_YET_RECRUITING